[CONTRIBUTION TO THE BIOCHEMISTRY OF AN  EXPERIMENTAL LIVER CIRRHOSIS AND ON THE POSSIBILITY OF CONTROLLING IT PHARMACOLOGICALLY].
D000818:Animals; D001669:Biochemical Phenomena; D001671:Biochemistry; D003094:Collagen; D003348:Cortisone; D006025:Glycosaminoglycans; D006595:Hexosamines; D006909:Hydroxyproline; D008103:Liver Cirrhosis; D008106:Liver Cirrhosis, Experimental; D009277:Nandrolone; D010653:Phenylbutazone; D051381:Rats; D012106:Research; D013409:Sulfacetamide; D014116:Toxicology
D006025:Glycosaminoglycans; D006595:Hexosamines; D013409:Sulfacetamide; D009277:Nandrolone; D003094:Collagen; D010653:Phenylbutazone; D006909:Hydroxyproline; D003348:Cortisone
BIOCHEMISTRY; COLLAGEN; CORTISONE; EXPERIMENTAL LAB STUDY; HEXOSAMINES; HYDROXYPROLINE; LIVER CIRRHOSIS, EXPERIMENTAL; MUCOPOLYSACCHARIDES; NANDROLONE; PHENYLBUTAZONE; RATS; SULFACETAMIDE; TOXICOLOGIC REPORT
BEITRAG ZUR BIOCHEMIE EINER EXPERIMENTELLEN LEBERCIRRHOSE UND ZUR MOEGLICHKEIT, SIE PHARMAKOLOGISCH ZU BEEINFLUSSEN.